Status:
WITHDRAWN
The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Depressive Disorder, Major
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will increase HRV at the end of the treatment.
Detailed Description
Phase advance of HRV will be anticipated in agomelatine group. It is anticipated that both agomelatine and floxentine will have equal efficacy in improvement of depressive symptoms and increasement of...
Eligibility Criteria
Inclusion
- Asian patients
- Male or female
- 18 to 65 years outpatients
- DSM-IV-TR criteria for Major Depressive Disorder
Exclusion
- Patients with cardiac conditions and other physical conditions contraindicated for drug study
- Shift worker
- Patients known to be non-responders to fluoxetine treatment
- Pregnancy, or breastfeeding
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00451490
Start Date
October 1 2006
End Date
December 1 2007
Last Update
January 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100